By the end of the treatment, the dissected hepatic tumor from the AOA treatment mice group without GPT1 overexpression showed about a 60% tumor size reduction, while the dissected hepatic tumor from the AOA treatment mice group with GPT1 overexpression showed only a 20% tumor size reduction as compared to the untreated group of mice without GPT1 overexpression (Figure 3F). The gene discussed is GPT; the disease is neoplasm.